Nuvation Bio is downgraded from Buy to Hold as its stock price now reflects improved Ibtrozi rollout visibility and strong fundamentals. Ibtrozi's commercial launch is robust, with early patient ...

Bio-Rad is a "picks and shovels" company in the life sciences industry, but lacks standout growth, margins, or returns, and that has been largely true for more than two decades. Recent trends in the ...

SAN DIEGO--(BUSINESS WIRE)--Nuvie Bio, a new clinical-stage biopharmaceutical company dedicated to addressing the most pressing unmet medical needs in migraine and related neurological diseases, ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Be Biopharma, Inc. (“Be Bio” or “the Company”), a leader in the discovery and development of engineered B Cell Medicines (BCMs), today announced key milestones ...

On Oct. 15, Modifi Bio, a Yale-based biotech company, closed an acquisition deal with Merck, an American pharmaceutical company, with $30 million paid upfront and up to $1.3 billion in developmental ...

If you were tasked with resurrecting an extinct animal, where would you even begin? Colossal Biosciences, a synthetic biology company founded in 2021 by a Harvard geneticist George Church and ...

NEW YORK and SANTA BARBARA, Calif., July 22, 2024 (GLOBE NEWSWIRE) -- Phytanix Bio, an innovative pharmaceutical company dedicated to the development of therapeutics based on cannabinoid and ...

The financing, led by Supply Change Capital with participation by Mondelez International’s SnackFutures Ventures and other backers, will help the 2-year-old company scale production of its ...

FibroBiologics, Inc., a clinical-stage biotechnology company specializing in fibroblast-based therapies, announced that CEO Pete O’Heeron will present a company update at the BIO International ...

PALI-2108 Abstracts Highlight Gut-Targeted PDE4B Inhibition and Translational Phase 1a Findings in Ulcerative Colitis ...

Going into 2026, biotech company Ladder Bio is embracing a new identity.